AnalystsPaul JengPaul Jeng's Stock Forecasts
AnalystsPaul Jeng
Sectors:
Industries:
Analyst Ranking
Bottom 8%
#5139 out of 5549 analysts
Average Return
-17.01%
Win Rate
38%6 out of 16
Risk vs Reward
Poor
Good
Paul Jeng's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ideaya Biosciences IncIDYA | +47.25% | $26.22 | $38.61 | 2025-09-18 - 2026-09-17 | Strong Buy |
Adagene IncADAG | +41.05% | $1.90 | $2.68 | 2025-11-24 - 2026-10-29 | Strong Buy |
Immatics NvIMTX | +33.43% | $6.61 | $8.82 | 2025-09-18 - 2026-09-17 | Strong Buy |
Kazia Therapeutics LtdKZIA | +6.60% | $8.18 | $8.72 | 2026-10-21 - 2026-10-29 | Strong Buy |
Ideaya Biosciences IncIDYA | +6.37% | $30.92 | $32.89 | 2026-02-18 - 2026-10-29 | Strong Buy |
Paul Jeng Analyst Color
Get additional color on Paul Jeng's coverage of popular stocks
Paul Jeng's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kazia Therapeutics LtdKZIA | 1 | Strong Buy | $35.00 | +301.38% | Initiates Coverage On | 9 days ago |
Nanobiotix SaNBTX | 1 | Strong Buy | $64.00 | +89.35% | Assumes | a month ago |
Ideaya Biosciences IncIDYA | 4 | Strong Buy | $57.00 | +73.30% | Maintains | 2 months ago |
Erasca IncERAS | 1 | Strong Buy | $21.00 | +40.19% | Maintains | 3 months ago |
Coherus Oncology IncCHRS | 1 | Strong Buy | $10.00 | +1,013.59% | Maintains | 3 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 2 | Strong Buy | $45.00 | +966.35% | Reiterates | 6 months ago |
Adagene IncADAG | 2 | Strong Buy | $10.00 | +273.13% | Maintains | 7 months ago |
Context Therapeutics IncCNTX | 2 | Strong Buy | $5.00 | +2,375.25% | Reiterates | 7 months ago |
Immatics NvIMTX | 2 | Strong Buy | $19.00 | +159.92% | Maintains | a year ago |
Immunocore Holdings PLCIMCR | 1 | Hold | N/A | N/A | Assumes | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.